Product
Mibavademab-Placebo
1 clinical trial
1 indication
Indication
ObesityClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityStatus: Not yet recruiting, Estimated PCD: 2025-12-01